Accuracy Coverage Pricing Contact
Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc (ALXN)

A global biopharmaceutical company focussed on alleviating or eradicating rare diseases in patients. The company serves patients in ca. 50 countries and is headquartered in Connecticut, USA. Their breakthrough product, Soliris ®,  is used to treat two extremely rare, life threatening disorders. Alexion has been added to both the NASDAQ-100 and S&P 500 indices.
[ALXN:US]

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount

Recent news articles

Investment Tools Limited

The Telegraph online declared ‘Budget 2015 – Investors face tax raid on dividends’. Whilst this is true for those with large income portfolios, not everybody loses out and in fact those who do not currently invest in stocks and shares, there is now a tax incentive to do so.

Read more

Alexion Pharmaceuticals Inc optimized dividend - 12 month history

Optimized dividend graph demo

Alexion Pharmaceuticals Inc share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial